B+
Bull case
25%
Probability
Target price
$11.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
SGHT
Sight SciencesBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The Q2 update supports a constructive operating trajectory: total revenue accelerated to 20% growth, IDE reached record sales, reimbursement access expanded, and management raised revenue guidance while reducing adjusted operating-expense guidance. [#SEC-8K-2026-08-05]
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +8.0.
What can break
IDE growth is from a small base, and expanded reimbursement access may not translate into procedure utilization.
Momentum
99
Value
37
Sentiment
73
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.60 · Bull $11.50 · Bear $5.30Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $9.00
Why
Momentum99 · Δ7d +0.1
Value37 · Δ7d -0.0
Sentiment73 · Δ7d +8.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +8.0.
Contradictions & invalidation
- • IDE growth is from a small base, and expanded reimbursement access may not translate into procedure utilization.
- • Interventional Glaucoma, the larger segment, grew 8% in Q2; sustained volume and ordering-account growth remain important.
- • The thesis still depends on converting reimbursement access and OMNI Ultra clearance into durable procedure volume.
Catalyst clock
2026-08-05
Q2 revenue acceleration and raised FY26 outlook
Lead driver: Sentiment · See AI snapshot
Momentum
99
9% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
73
62% active weight
Current posture
7d trendImproving
Δ7d
+8.0
Δ21d
-
Why this grade
Composite grade B. Momentum 98.6 / Value 36.6 / Sentiment 73.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$8.60
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$5.30
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$453.93M
Beta
2.41
Shares Out
55.09M
P/E (TTM) · Derived
-11.2
P/S (TTM)
5.36
P/FCF (TTM) · Derived
-18.86
Rev YoY
+19.5%
EPS YoY
-64.6%
Gross Margin
+88.0%
Op Margin
-33.4%
Net Debt
-$51.19M
Current Ratio
4.95
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data